Compound Diisopropylamine Dichloroacetate Injection – (Shibeixin) – 20?mg Low price comparison
$2.00
Shibeixin Compound Diisopropylamine Dichloroacetate Injection delivers 20?mg of active compound per 1?ml vial, with 10 vials per box. Manufactured by Hunan Wuzhoutong Pharmaceutical Co., Ltd. Approved under NMPA number H20067194. Widely used for preclinical research on liver metabolism, fatty liver, and bile secretion enhancement.
?? For laboratory and research use only—Not for clinical application.?Please consult staff for other specifications and uses?
描述
Compound Diisopropylamine Dichloroacetate (commonly known as DADA injection, brand Shibeixin) combines diisopropylamine dichloroacetate with sodium gluconate. DADA, a derivative of pangamic acid (“Vitamin B15”), is a hepatoprotective agent that enhances metabolic enzyme activity, supports liver detoxification, and improves bile flow. The injectable form is suitable for experimental and pharmacological studies on liver disorders, such as fatty liver, hepatic impairment, and early-stage cirrhosis.
Shibeixin is produced by Hunan Wuzhoutong Pharmaceutical Co., Ltd., following NMPA approval H20067194. Packaged as sterile liquid, 1?ml (20?mg) per vial × 10 vials.
Product Specifications
| Parameter | Details |
|---|---|
| Product Name | Compound Diisopropylamine Dichloroacetate Injection (Shibeixin) |
| Active Ingredient | Diisopropylamine Dichloroacetate (DADA) + Sodium Gluconate |
| CAS Number (DADA) | 660?27?5 |
| Molecular Formula (DADA) | C?H??Cl?NO? |
| Molecular Weight (DADA) | 230.13?g/mol |
| Appearance | Clear, colorless sterile injection solution |
| Strength | 20?mg per 1?ml vial |
| Pack Size | 10 vials per box |
| Dosage Form | Injectable solution |
| Approval Number | H20067194 (NMPA, China) |
| Manufacturer | Hunan Wuzhoutong Pharmaceutical Co., Ltd. |
| Barcode | Not yet assigned—ask for packaging data |
| Storage Conditions | Store ??25?°C, avoid light |
| Intended Use | Lab research—liver protection, metabolism, bile secretion studies |
Mechanism of Action
DADA enhances liver metabolism by stimulating hepatic phospholipid methylation, increasing membrane fluidity, and activating Na?/K??ATPase. It supports mitochondrial respiration and promotes bile secretion, aiding in reducing fatty accumulation in hepatocytes.
Research Applications
-
Fatty liver disease models
-
Hepatic bile secretion and cholestasis studies
-
Liver function recovery assays
-
Hepatitis and early fibrosis/pre-cirrhosis experiments
-
NADH/NAD metabolism and mitochondrial respiration research
Safety & Handling
-
Use appropriate lab PPE (gloves, gown, eye protection)
-
Intended for lab/experimental use only—no clinical administration
-
Reported mild adverse effects in clinical contexts: dizziness, nausea, hypotension
-
Store sealed, away from moisture and light
Core Keywords
DADA injection, compound diisopropylamine dichloroacetate, pangamic acid injection, Shibeixin injection, fatty liver research, liver metabolism injection, bile secretion enhancer, hepatoprotective injection
Research Use Disclaimer
This product is strictly for laboratory/research use. It is not approved for clinical, diagnostic, therapeutic, or veterinary applications. Misuse may pose legal or health risks—follow institutional protocols.
其他信息
| 重量 | 1 公斤 |
|---|---|
| 尺寸 | 26 × 23 × 28 厘米 |
相关产品
-
Entecavir Tablets 0.5?mg (Teganning / Youhua Pharmaceutical) Low price wholesale comparison
Teganning (Youhua Pharmaceutical) Entecavir Tablets deliver 0.5?mg of entecavir per tablet in a 30-tablet bottle. Manufactured by Zhengzhou Taifeng Pharmaceutical Co., Ltd., with NMPA approval H20213401 . Ideal for preclinical and laboratory research in antiviral therapy targeting chronic hepatitis B infections.
?? For laboratory and research use only. Not for diagnostic or therapeutic use.?Please consult staff for other specifications and uses? $2.00 -
Entecavir Dispersible Tablets 0.5?mg (Aipuding ) – Wholesale & Retail
Entecavir Dispersible Tablets (Aipuding / ???) deliver 0.5?mg entecavir per tablet in a fast?dissolving oral format, with 28 tablets per box. Manufactured by Hunan Qianjin Xieli Pharmaceutical Co., Ltd. (NMPA H20140093), this antiviral agent is extensively used in chronic hepatitis B research and clinical studies.?? For research and clinical use only.?Please consult staff for other specifications and uses? $2.00 -
N?Acetylcysteine Injection 4?g (Minsheng / Asixintai)
Minsheng (Asixintai) N?Acetylcysteine Injection delivers 4?g per 20?ml vial in a sterile solution. Manufactured by Hangzhou Minsheng Pharmaceutical Co., Ltd., approved under NMPA H20051788. Widely used in preclinical research for hepatoprotective, antioxidant, and mucolytic applications.
?? For laboratory and research use only.?Please consult staff for other specifications and uses? $1.00 -
Compound Ammonium Glycyrrhetate (Yingtiancheng) Low price wholesale
Yingtiancheng Compound Ammonium Glycyrrhetate Injection offers a hepatoprotective formula in 5 vials of 20?ml each. Produced by Hebei Tiancheng Pharmaceutical Co., Ltd., approved under NMPA H13023812. Ideal for lab studies involving liver function, inflammation, and oxidative stress.?? For laboratory research use only. Not for clinical or therapeutic use.?Please consult staff for other specifications and uses? $2.00
评价
目前还没有评价